NICE backs daratumumab quadruplet for transplant‑eligible myeloma PharmaTimes 13h Blood Cancer Johnson and Johnson Pharma All sources
Supreme Court lens on stem cell therapy for autism Hindustan Times 19h Crime in India India Global Health
Haploidentical HSCT may be more cost-effective than gene therapy in scd Hematology Advisor 1d HSCT Biology All sources
